Factors associated with decreased bone mineral density in postmenopausal women with schizophrenia.

Ying Liang,Jian Huang,Jing-bin Tian,Yuan-yuan Cao,Guo-ling Zhang,Chun-gang Wang,Ying Cao,Jian-rong Li
DOI: https://doi.org/10.2147/CIA.S100274
IF: 3.829
2016-01-01
Clinical Interventions in Aging
Abstract:Objective: This study examined the risk factors for decreased bone mineral density (BMD) in postmenopausal women with schizophrenia. Methods: Cluster sampling method was adopted in this large-sample, cross-sectional study. A total of 219 postmenopausal female inpatients with schizophrenia were selected and interviewed in Beijing. The average age of the patients was 60.4 +/- 7.0 years. Clinical assessment instruments included the Positive and Negative Syndrome Scale (PANSS) and a questionnaire with detailed general information and disease-related investigations. Laboratory measurements included prolactin (PRL), estradiol, progesterone, thyroid stimulating hormone, FT3, and FT4. BMD testing was performed by dual-energy X-ray absorptiometry. Results: The prevalence of osteoporosis or osteopenia was 66.2% (n=145). Decreased BMD was associated with age, illness duration, therapeutic dose (equivalent chlorpromazine dose), treatment duration, PANSS-negative scores, body mass index (BMI), daily exercises (min/d), drinking (unit/wk), PRL, and estradiol. Multiple logistic regression analysis revealed that age, treatment duration, PANSS-negative score, BMI, and PRL were significantly associated with decreased BMD. Conclusion: Prevalence of BMD loss was higher in Chinese postmenopausal women with schizophrenia compared to the normal BMD group. A combination of demographic and clinical factors play important roles in determining decreased BMD, including older age, longer treatment duration, more PANSS-negative scores, higher BMI, and higher PRL level.
What problem does this paper attempt to address?